IP Library Granted Patent US 7,741,442
Granted Patent B2
US 7,741,442 · App. 11/218,473 · Granted Jun 22, 2010

Antibody composition exhibiting increased cellular cytotoxicity due to glycosylation

Assignee: Kyowa Hakko Kirin Co., Ltd
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,741,442
App. No.
11/218,473
Granted
Jun 22, 2010
Kind
B2
Abstract

The present invention relates to a cell for the production of an antibody molecule such as an antibody useful for various diseases having high antibody-dependent cell-mediated cytotoxic activity, a fragment of the antibody and a fusion protein having the Fc region of the antibody or the like, a method for producing an antibody composition using the cell, the antibody composition and use thereof.

Claims (10)

1. An antibody composition comprising antibody molecules, wherein 50% or more of the molecules comprise a Fc region comprising complex N-glycoside-linked sugar chains bound to the Fc region,

wherein said sugar chains comprise a reduced terminal which contains an N-acetylglucosamine;

wherein said sugar chains do not contain fucose bound to the 6-position of the N-acetylglucosamine in the reducing terminal of the sugar chains; and

wherein said antibody molecules bind to an antigen selected from the group consisting of ganglioside GD3, ganglioside GM2, HER-2, a vascular endothelial cell growth factor receptor, CCR4, an interleukin-5 receptor and a tumor necrosis factor.

2. The antibody composition according to claim 1 , wherein the antibody molecules are molecules selected from the group consisting of (a), (b) and (c):

(a) human antibodies;

(b) humanized antibodies;

(c) antibody fragments.

3. The antibody composition according to claim 1 , wherein the antibody molecules belong to an IgG class.

4. A composition comprising the antibody composition according to claim 1 and a carrier.

Assignments (2)
CHANGE OF NAME AND ADDRESS Recorded Oct 23, 2019
From: KYOWA HAKKO KIRIN CO., LTD.
To: KYOWA KIRIN CO., LTD.
Reel/Frame 050797/0533 →
CHANGE OF NAME Recorded Mar 17, 2009
From: KYOWA HAKKO KOGYO CO., LTD.
To: KYOWA HAKKO KIRIN CO., LTD.
Reel/Frame 022542/0823 →
Priority Claims (2)
JP P 2000-308526 · Oct 6, 2000 · national
WO PCT/JP01/08804 · Oct 5, 2001 · international
Continuity (3)
Division 0997177300 · Oct 9, 2001
Provisional Application 6026891600 · Feb 16, 2001
Related Publication 20060063254A1 · Mar 23, 2006